Demand Generation I-Kit for Underutilized, Life Saving Commodities

Spotlight on Magnesium Sulfate for Pre-eclampsia and Eclampsia

The risk that a woman in a developing country will die of PE/E is approximately 300 times higher than that for a woman in a developed country. Magnesium sulfate (MgSO4) is the most effective medication for the prevention and treatment of PE/E, yet remains underutilized. It is one of 13 underutilized commodities identified by the UN Commission on Life-Saving Commodities for Women’s and Children’s Health that if more widely accessed and properly used, could save the lives of more than six million women and children worldwide. The second leading cause of maternal death worldwide is pre-eclampsia and eclampsia (PE/E). It’s most often detected through the elevation of blood pressure during pregnancy, which can lead to seizures, kidney and liver damage, and death, if untreated.

pdf icon Spotlight on Magnesium Sulfate for Pre-eclampsia and EclampsiaThe second leading cause of maternal death worldwide is pre-eclampsia and eclampsia (PE/E). It’s most often detected through the elevation of blood pressure during pregnancy, which can lead to seizures, kidney and liver damage, and death, if untreated.

Year of Publication: 2014

Length: 2 pages

Languages: English, French

 

For additional information on developing a demand generation communication strategy for magnesium sulfate, visit this extended component.

Copyright © Johns Hopkins University, All Rights Reserved

USAID LogoThis website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the Health Communication Capacity Collaborative (HC3) Cooperative Agreement #AID-OAAA-A-12-00058. On-going support is provided by Breakthrough ACTION with support from USAID’s Bureau for Global Health, under Cooperative Agreement #AID-OAA-A-17-00017. Breakthrough ACTION is based at the Johns Hopkins Center for Communication Programs (CCP). The contents of this website are the sole responsibility of Breakthrough ACTION and do not necessarily reflect the views of USAID, the United States Government, or the Johns Hopkins University.